Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN-199201 and AGN-190584 in presbyopia
NCT02780115Phase 2Completed
- Sponsor
- Allergan
- Start
- May 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AGN-199201 and Aurocarpine in presbyopia, sponsored by Allergan. Started May 2016; status: completed.
02
Drugs
AGN-199201Aurocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT02780115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02780115.